| Financial Year |
March 31 2023 |
| Monetary Funds |
21,534,332.65 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
7,417,318.95 |
| Accounts Receivable |
25,811,603.44 |
| Advances to Suppliers |
1,624,600.84 |
| Other Receivables |
92,179,674.14 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
104,284,817.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
20,902,567.37 |
| Total Current Assets |
276,579,978.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
49,749,241.60 |
| Investment Properties |
-- |
| Fixed Assetes |
883,706,818.13 |
| Under-construction Projects |
56,727,335.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
210,103,934.22 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
30,935,274.20 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
60,275,825.24 |
| Sub-Total of Non-Current Assets |
1,303,477,030.77 |
| Total Assets |
1,580,057,008.98 |
| Short-Term Loans |
157,181,763.88 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
183,547,490.96 |
| Accounts Received In Advance |
27,092.67 |
| Employee Compensation Payable |
8,844,205.04 |
| Taxes Payable |
14,874,367.05 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,736,750.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
72,199,534.65 |
| Other Current Liabilities |
8,625,352.78 |
| Sub-Total of Current Liabilities |
456,340,553.73 |
| Long-term Loans |
227,151,107.30 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
188,175.73 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
252,635,726.99 |
| Total Liabilities |
708,976,280.72 |
| Paid-In Capital(Or Share Stock) |
204,650,000.00 |
| Capital Surplus |
565,633,229.11 |
| Surplus Reserve |
42,235,883.15 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
57,696,532.10 |
| Minority Stockholder's Interest |
733,648.36 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
870,347,079.90 |
| Owner's Equity（Stockholder's Equity） |
871,080,728.26 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,580,057,008.98 |
